1998
DOI: 10.1136/bmj.317.7156.441
|View full text |Cite
|
Sign up to set email alerts
|

Deliberate self harm: systematic review of efficacy of psychosocial and pharmacological treatments in preventing repetition

Abstract: The difference may be partly accounted for by the factors that influence infectivity of the two viruses. Hepatitis B is much more likely to be transmitted from mother to infant if there is a high concentration of the virus in the mother's blood. This explains the ethnic differences that are observed-for example, the transmission rate is over 70% in Chinese women but less than 10% in white women. This ethnic difference does not seem to apply to hepatitis C infection.Alcohol intake and obesity are both thought t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
291
1
3

Year Published

1999
1999
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 388 publications
(298 citation statements)
references
References 38 publications
3
291
1
3
Order By: Relevance
“…We have considerably expanded the range of outcome variables compared with the original version of our review. 11 This often required correspondence with authors to obtain unpublished data. Different measures were used in the assessment of some outcome variables which may have impacted on the results.…”
Section: Strengths and Limitationsmentioning
confidence: 99%
See 1 more Smart Citation
“…We have considerably expanded the range of outcome variables compared with the original version of our review. 11 This often required correspondence with authors to obtain unpublished data. Different measures were used in the assessment of some outcome variables which may have impacted on the results.…”
Section: Strengths and Limitationsmentioning
confidence: 99%
“…10 Given the size of the problem of self-harm, the frequency with which it is repeated, and the risk of subsequent suicide, it is important that effective treatment interventions are developed for this patient population. We previously published a systematic review and meta-analysis of both psychosocial and pharmacological treatment studies across the age spectrum in 1998, 11 which was subsequently updated in an official guideline in 2011. 12 We have recently conducted a major update of this review in conjunction with the Cochrane Collaboration.…”
Section: Introductionmentioning
confidence: 99%
“…One valuable approach to understanding the dynamics of suicide has been the use of psychological autopsies [14]. Based on interviews of relatives of the deceased and evidence from medical, criminal and social services records, psychological autopsy studies suggest that more than 90% of young suicide deaths are associated with mental health disorders, and high rates of comorbid mental health, addictive and physical disorders [5,25,27].…”
Section: Introductionmentioning
confidence: 99%
“…Repetition itself increases the risk of a fatal outcome (Sakinofsky, 2000). The results of both psychosocial and pharmacological interventions to prevent repetition have been fairly disappointing (Hawton et al 1998, although the findings of treatment trials have not all been negative. Dialectical behaviour therapy had a substantial initial impact on repetition of self-harm, although this did not persist in a treatment study of female patients with borderline personality disorders (Linehan et al 1991) and depot flupenthixol reduced repetition in frequent self-harmers (Montgomery, 1987).…”
Section: Editorialmentioning
confidence: 99%
“…One of the main drawbacks of most treatment studies to date involving DSH patients has been their relatively small size and hence limited power (Hawton et al 1998). Given the large number of DSH patients presenting to general hospitals (Kapur & House, 1998;Wilkinson et al 2002) and the need to target this population as part of national suicide prevention strategies, for example the Department of Health in the UK in 2002, there is a need for robust information from large trials of pragmatic treatments suitable for application in NHS settings.…”
Section: The Need For Large Clinically Relevant Trialsmentioning
confidence: 99%